WVP health authority supports Senate Bill 295 amid clarity on treatment protocols

The Oregon Senate Committee on Health Care convened on March 25, 2025, to discuss significant legislative matters, including Senate Bill 295 and Senate Bill 1161. A key focus of the meeting was the implications of the "dash 1" amendment to Senate Bill 295, which aims to address treatment protocols for COVID-19.

During the discussions, representatives from the WVP Health Authority clarified their support for the base bill but expressed concerns about the amendment's potential limitations on future treatment options. The committee members engaged in a thorough examination of whether removing the sunset provision would restrict the adaptability of treatment protocols as new medications become available.

One committee member raised concerns about the amendment creating a "slippery slope" regarding treatment options, emphasizing the need for clarity on the bill's intent. In response, it was noted that the Pharmacy Formulary Advisory Committee (PFAC) would have the authority to update treatment protocols as necessary, ensuring that the system remains flexible and responsive to new developments in COVID-19 treatment.

The meeting concluded with a recognition of the efforts made over the past three years to address these health care issues, and the committee moved on to open a public hearing for Senate Bill 1161. The discussions highlighted the ongoing commitment of the Oregon legislature to adapt health care policies in response to evolving medical needs.